Skip to Content

11 17 WPI (Mirtazapine 15 mg)

Pill with imprint 11 17 WPI is White, Elliptical / Oval and has been identified as Mirtazapine 15 mg. It is supplied by Watson Pharmaceuticals.

Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 11 17 WPI

Mirtazapine 15 mg 11 17 WPI
Mirtazapine 15 mg 11 17 WPI Front
Mirtazapine 15 mg 11 17 WPI Back
Mirtazapine 15 mg 11 17 WPI

Mirtazapine

Imprint
11 17 WPI
Strength
15 mg
Color
White
Size
10.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Tetracyclic antidepressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
lactose anhydrous, silicon dioxide, magnesium stearate, microcrystalline cellulose, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-1117 Watson Pharmaceuticals, Inc.
63874-1098 Altura Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "11 17 WPI"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.